In re Nolan

553 F.2d 1261, 193 U.S.P.Q. (BNA) 641, 1977 CCPA LEXIS 153
CourtCourt of Customs and Patent Appeals
DecidedMay 5, 1977
DocketPatent Appeal No. 76-672
StatusPublished
Cited by6 cases

This text of 553 F.2d 1261 (In re Nolan) is published on Counsel Stack Legal Research, covering Court of Customs and Patent Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In re Nolan, 553 F.2d 1261, 193 U.S.P.Q. (BNA) 641, 1977 CCPA LEXIS 153 (ccpa 1977).

Opinion

MILLER, Judge.

This appeal is from the decision of the Patent and Trademark Office Board of Appeals (board) affirming the rejection under 35 USC 103 of claims 1 through 9, all of the claims in application serial No. 396,337, filed September 11, 1973, for “Multiple Gas Discharge Display/Memory Panel and Method of Operating.” We affirm.

The Invention

The invention is an improvement in a gaseous discharge display/memory device having an electrical memory and the capability of producing a visual display and the method of operating same. The improvement resides in the specific ionizable gaseous medium (i. e., “99.5 to 99.99 percent atoms of neon and about .5- to .01 percent atoms of at least one minority rare gas selected from argon, krypton, and xenon”) used in the device.

The device is exemplified by Figures 3 and 4 of appellant’s drawings:1

[1263]*1263 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

Free access — add to your briefcase to read the full text and ask questions with AI

Related

GRACEWAY PHARMACEUTICALS, LLC v. Perrigo Co.
722 F. Supp. 2d 566 (D. New Jersey, 2010)
In Re Eli Lilly & Company
902 F.2d 943 (Federal Circuit, 1990)
Hybritech Inc. v. Monoclonal Antibodies, Inc.
623 F. Supp. 1344 (N.D. California, 1985)
In re Magerlein
602 F.2d 366 (Customs and Patent Appeals, 1979)
In re May
574 F.2d 1082 (Customs and Patent Appeals, 1978)
In re Greenfield
571 F.2d 1185 (Customs and Patent Appeals, 1978)

Cite This Page — Counsel Stack

Bluebook (online)
553 F.2d 1261, 193 U.S.P.Q. (BNA) 641, 1977 CCPA LEXIS 153, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-nolan-ccpa-1977.